MX9302549A - Proteina receptora especifica para la region csvt cg de la trombospondina y metodo para su purificacion y caracterizacion. - Google Patents
Proteina receptora especifica para la region csvt cg de la trombospondina y metodo para su purificacion y caracterizacion.Info
- Publication number
- MX9302549A MX9302549A MX9302549A MX9302549A MX9302549A MX 9302549 A MX9302549 A MX 9302549A MX 9302549 A MX9302549 A MX 9302549A MX 9302549 A MX9302549 A MX 9302549A MX 9302549 A MX9302549 A MX 9302549A
- Authority
- MX
- Mexico
- Prior art keywords
- thrombospondin
- purification
- region
- csvt
- characterization
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención proporciona un receptor de matriz celular específico para la región CSVTCG de la trombospondina. También proporciona los métodos de purificación, clonación y expresión. Los anticuerpos dirigidos contra la proteína receptora son útiles en numerosas áreas de diagnóstico, profilácticas y terapéuticas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/883,659 US5367059A (en) | 1992-05-14 | 1992-05-14 | Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9302549A true MX9302549A (es) | 1994-07-29 |
Family
ID=25383057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9302549A MX9302549A (es) | 1992-05-14 | 1993-04-30 | Proteina receptora especifica para la region csvt cg de la trombospondina y metodo para su purificacion y caracterizacion. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5367059A (es) |
EP (1) | EP0578342A3 (es) |
JP (1) | JPH07138296A (es) |
CA (1) | CA2095404A1 (es) |
MX (1) | MX9302549A (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627265A (en) * | 1993-03-05 | 1997-05-06 | Washington University | Receptor for cell-binding domain of thrombospondins |
EP0730466A4 (en) * | 1993-09-10 | 1999-04-14 | Univ New York | COMPOSITIONS AND METHOD FOR INHIBITING THE INVASION OF HEPATOCYTES BY MALARIASPOROZOITES |
GB9509957D0 (en) * | 1995-05-17 | 1995-07-12 | Khalil Nasreen | Post-translational activation of tgf-1 involving the tsp-1 receptor cd36 |
US6716963B1 (en) | 1998-05-22 | 2004-04-06 | Abbott Laboratories | Peptide antiangiogenic drugs |
AU5498100A (en) * | 1999-06-21 | 2001-01-09 | Paul Actor | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
US6380161B1 (en) | 1999-06-21 | 2002-04-30 | Inkine Pharmaceutical Company, Inc. | Compositions for treating chemotherapy-resistant tumor cells and targeted chemotherapy compositions |
WO2001005968A1 (en) * | 1999-06-21 | 2001-01-25 | Inkine Pharmaceutical Company, Inc. | Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192744A (en) * | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
US5190920A (en) * | 1990-09-24 | 1993-03-02 | W. R. Grace & Co.-Conn. | Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity |
AU2795892A (en) * | 1991-10-03 | 1993-05-03 | Center For Blood Research, The | Cd36 immunoadhesins and their use in selectively killing (plasmodium falciparum) infected erythrocytes |
WO1993022340A1 (en) * | 1992-04-30 | 1993-11-11 | Schering Corporation | Modulation of thrombospondin-cd36 interactions |
-
1992
- 1992-05-14 US US07/883,659 patent/US5367059A/en not_active Expired - Lifetime
-
1993
- 1993-04-30 MX MX9302549A patent/MX9302549A/es unknown
- 1993-05-03 CA CA002095404A patent/CA2095404A1/en not_active Abandoned
- 1993-05-11 EP EP19930250135 patent/EP0578342A3/en not_active Withdrawn
- 1993-05-12 JP JP5132353A patent/JPH07138296A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0578342A2 (en) | 1994-01-12 |
CA2095404A1 (en) | 1993-11-15 |
EP0578342A3 (en) | 1994-06-29 |
JPH07138296A (ja) | 1995-05-30 |
US5367059A (en) | 1994-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL331091A1 (en) | Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor | |
ES2168376T3 (es) | Anticuerpos que activan un receptor de eritropoyetina. | |
NO331148B1 (no) | Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose. | |
EE03424B1 (et) | Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod | |
WO1999004265A3 (en) | Cancer associated nucleic acids and polypeptides | |
TR199700652T1 (xx) | �nsan interl�kosit-1 resept�r yard�mc� proteini. | |
DE69521369D1 (de) | Anzeigeverfahren für einen gemeinsamen virtuellen Raum und Vorrichtung unter Verwendung dieses Verfahrens | |
ATE163195T1 (de) | Lösliche liganden für cd40 | |
EP0959896A4 (en) | COMPOSITIONS BASED ON THE HUMAN THYROTROPIN RECEPTOR AND THEIR USE | |
TR200000930T2 (tr) | Büyüme hormonu sekretagogları. | |
DE97905729T1 (de) | Als 2f1 bezeichnetes rezeptorprotein | |
ATE255632T1 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
PL319374A1 (en) | Region v proteins of t cell antigen receptor and method of obtaining them | |
IT1308673B1 (it) | Apparecchio e procedimento per applicare automaticamente smalto perunghie. | |
UA27035C2 (uk) | Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму | |
DK0747471T3 (da) | Proteasebehandlede og oprensede cellulase-sammensætninger samt fremgangsmåder til at reducere tilbagefarvning under enzymat | |
MX9302549A (es) | Proteina receptora especifica para la region csvt cg de la trombospondina y metodo para su purificacion y caracterizacion. | |
TR199901636T2 (xx) | �mm�nolojik hastal�klar�n tedavisi i�in terap�tik maddeler olarak ��z�n�r lenfotoksin-beta resept�rleri, anti-lenfotoksin resept�r� antikorlar� ve anti-lenfotoksin ba�� antikorlar�. | |
PT946873E (pt) | Metodos para diagnostico da aspergilose broncopulmonar alergica | |
ES2121358T3 (es) | Anticuerpos monoclonales humanizados contra interleuquina-4 humana. | |
DK0538341T3 (da) | EHV-4-gycoproteinvaccine. | |
PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
NO993180L (no) | N-(pyridinylamino)isoindoler og beslektede forbindelser | |
WO1996022760A3 (en) | Antagonists of alpha-melanocyte stimulating hormone and methods based thereon | |
BR9711138A (pt) | Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas |